Journal article
B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation
C Tay, YH Liu, H Hosseini, P Kanellakis, A Cao, K Peter, P Tipping, A Bobik, BH Toh, T Kyaw
Cardiovascular Research | OXFORD UNIV PRESS | Published : 2016
DOI: 10.1093/cvr/cvw186
Abstract
Aims B2 lymphocytes promote atherosclerosis development but their mechanisms of action are unknown. Here, we investigated the role of tumour necrosis factor alpha (TNF-α) produced by B2 cells in atherogenesis. Methods and results We found that 50% of TNF-α-producing spleen lymphocytes were B2 cells and ∼20% of spleen and aortic B cells produced TNF-α in hyperlipidemic ApoE-/- mice. We generated mixed bone marrow (80% μMT/20% TNF-α-/-) chimeric LDLR-/- mice where only B cells did not express TNF-α. Atherosclerosis was reduced in chimeric LDLR-/- mice with TNF-α-deficient B cells. TNF-α expression in atherosclerotic lesions and in macrophages were also reduced accompanied by fewer apoptotic ce..
View full abstract